Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) ("Nanobac" or "the Company?) is pleased to announce a jointly signed letter of intent for the acquisition of DNAPrint Genomics, Inc...
NEW YORK, Sept. 7 /PRNewswire-FirstCall/ -- Richard Gabriel, Chief Executive Officer of DNAPrint Genomics, Inc. (OTC:DNAG) (BULLETIN BOARD: DNAG) (http://www.dnaprint.com/) will be featured in...
DNAPrint genomics Launches New Corporate Marketing and Product Branding Campaign Features Two Redesigned and Upgraded Web Sites SARASOTA, Fla., July 25 /PRNewswire-FirstCall/ -- DNAPrint...
DNAPrint genomics' Forensics Technology Featured in Presentation to Florida Sex Crimes Investigators Association SARASOTA, Fla., July 18 /PRNewswire-FirstCall/ -- DNAPrint genomics...
DNAPrint genomics Acquires 18% Stake in German Company Creates New Product Pipeline for Pharmaceutical Products SARASOTA, Fla., July 13 /PRNewswire-FirstCall/ -- DNAPrint genomics...
DNAPrint genomics Upgrades Genotyping Platform SARASOTA, Fla., July 12 /PRNewswire-FirstCall/ -- DNAPrint genomics, Inc. (OTC:DNAG) (BULLETIN BOARD: DNAG) today announced an upgrade in the...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 6250 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 2180 | 2.83E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 59802 | 1.05E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 115263 | 1.01E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.000134 | 1.0E-6 | 112048 | 1.09E-6 | CS |
260 | 0 | 0 | 1.0E-6 | 0.001 | 1.0E-6 | 741156 | 0.00035125 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales